Q2 2019 Holdings
Filed 2019-08-14 | 43 holdings | $111.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-04-09) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $25.9M | 225,000 | 23.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $21.9M | 850,000 | 19.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $20.0M | 750,000 | 18.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $14.2M | 100,000 | 12.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $10.9M | 150,000 | 9.8% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $9.5M | 2,500,000 | 8.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $4.9M | 225,000 | 4.4% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $3.9M | 175,000 | 3.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $44.1K | 290,000 | 0.0% |
| Spdr Series Trust(XBI)PutA | S&P BIOTECH | 78464A870 | $43.9K | 500,000 | 0.0% |
| Invesco QQQ TR(QQQ)PutA | UNIT SER 1 | 46090E103 | $37.3K | 200,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $35.4K | 375,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $34.5K | 335,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $18.1K | 1,450,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $15.8K | 300,000 | 0.0% |
| Immunomedics Inc(IMMU)CallA | COM | 452907108 | $11.1K | 800,000 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $9.0K | 300,000 | 0.0% |
| Invesco Curncyshs Swiss Fran(FXF) | SWISS FRANC | 46138R108 | $8.8K | 92,200 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $8.3K | 600,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $7.2K | 1,000,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $6.9K | 460,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.6K | 300,000 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $6.6K | 750,000 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $6.5K | 240,000 | 0.0% |
| Pfizer Inc(PFE)PutA | COM | 717081103 | $6.5K | 150,000 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $6.2K | 500,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $6.1K | 275,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $5.8K | 465,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $5.5K | 30,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $5.1K | 50,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $4.4K | 100,000 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $4.3K | 2,100,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $3.7K | 235,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $3.7K | 150,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $3.4K | 242,950 | 0.0% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $3.0K | 400,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.7K | 35,000 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $2.4K | 125,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $2.4K | 200,000 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $2.4K | 65,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $2.2K | 200,000 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $575 | 100,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $455 | 10,500 | 0.0% |